PATENT CLAIM ANALYSIS

Application Number: 16393775
Application Type: Utility
Filing Date: 2019-04
Publication Date: 2019-08
Patent Classification: ["544", "262000"]

Abstract:
Described herein is the Bruton's tyrosine kinase (Btk) inhibitor 1-((R)-3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one, including crystalline forms, solvates and pharmaceutically acceptable salts thereof. Also disclosed are pharmaceutical compositions that include the Btk inhibitor, as well as methods of using the Btk inhibitor, alone or in combination with other therapeutic agents, for the treatment of autoimmune diseases or conditions, heteroimmune diseases or conditions, cancer, including lymphoma, and inflammatory diseases or conditions.

Claim (Index 25):
The pharmaceutical formulation of  claim 24 , wherein the one or more disintegrating agents are selected from the group consisting of natural starch, a pregelatinized starch, a sodium starch, methylcrystalline cellulose, methylcellulose, croscarmellose, croscarmellose sodium, cross-linked sodium carboxymethylcellulose, cross-linked carboxymethylcellulose, cross-linked croscarmellose, cross-linked starch, cross-linked polymer, cross-linked polyvinylpyrrolidone, sodium alginate, a clay, and a gum.

Metadata:
- Claim Count in Document: 89.0
- Percentile: 100.0
- Lexical Diversity: 1.54688
- Patent Class: 544.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['16111014', '16110999', '15386118', '15670614', '14405317']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.858276034284794
- 35 USC 102 Novelty (BERT): 0.6800085012074072
- Combined Prediction Score: 0.8404492809770554
- Mean Citation Score: 663.9168420000002
- Max Citation Score: 707.8031599999997
- Similarity Product: 635.5586802323602

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test